Statistics

Hepatitis – the “silent killer”

Hepatitis is often called the silent killer because globally 95{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} of people with hepatitis are unaware of their infection as most sufferers show no symptoms. Over 13 million people in the European Region are estimated to be living with hepatitis B virus (HBV) infection, and over 15 million with chronic hepatitis C virus (HCV) infection.

Hepatitis – the “silent killer” Read More »

Pharmaceutical Expenditure And Policies

Across OECD countries, pharmaceutical spending was around US$800 billion in 2013, accounting for about 20{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} of total health spending on average (hospital consumption and retail). This paper ‘Pharmaceutical expenditure and policies: past trends and future challenges‘ examines the drivers of recent spending trends, highlighting differences across therapeutic classes. While the consumption of medicines continues to

Pharmaceutical Expenditure And Policies Read More »

OECD Health Statistics 2016

The online database ‘OECD health statistics 2016‘ has been released and offers the most comprehensive source of comparable statistics on health and health systems across OECD countries. It is an essential tool to carry out comparative analyses and draw lessons from international comparisons of diverse health systems. It includes data on biotechnology, cancer, health care,

OECD Health Statistics 2016 Read More »

Scroll to Top